Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
251 studies found for:    Open Studies | "Kidney Failure, Chronic"
Show Display Options
Rank Status Study
21 Recruiting MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients
Condition: Kidney Failure, Chronic
Intervention: Biological: Mitomycin C-induced peripheral blood mononuclear cells (MICs)
22 Recruiting Impact of Exercise on Cognitive Impairment in End-Stage Renal Disease
Conditions: Cognitive Impairment;   End-Stage Renal Disease
Interventions: Other: Aerobic Exercise;   Procedure: Standard Care Dialysis
23 Recruiting A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis
Conditions: End Stage Renal Disease;   Hyperphosphatemia
Intervention: Dietary Supplement: VS-505
24 Not yet recruiting Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)
Conditions: Atrial Fibrillation;   End-stage Kidney Disease
Interventions: Drug: Apixaban;   Drug: Phenprocoumon
25 Recruiting Registry for End Stage Renal Failure
Condition: End Stage Renal Failure
Intervention: Other: Registry (No intervention)
26 Recruiting Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
Conditions: Kidney Failure, Chronic;   Catheter-Related Infections
Interventions: Drug: Neutrolin;   Drug: Heparin
27 Recruiting The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease
Condition: End-stage Renal Disease
Interventions: Other: Eu- and hyperglycemic clamp;   Other: Arginine test
28 Recruiting A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
Conditions: Depression;   End Stage Renal Disease
Interventions: Behavioral: Engagement Interview;   Behavioral: Cognitive Behavioral Therapy;   Drug: Antidepressant Drug Therapy
29 Recruiting A Cluster-randomized, Pragmatic Trial of Hemodialysis Session Duration
Condition: End Stage Renal Disease
Intervention: Other: Dialysis session of at least 4.25 hours
30 Recruiting Mode of Dialysis Therapy and Outcomes in End Stage Renal Disease (ESRD)
Condition: End-Stage Renal Disease
Intervention:
31 Recruiting Effect of Beginning a Renal Replacement Therapy on Obstructive Sleep Apnea in End Stage Renal Disease Patients
Conditions: Obstructive Sleep Apnea;   End Stage Renal Disease
Interventions: Procedure: Renal replacement therapy;   Other: no intervention
32 Recruiting Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)
Condition: Kidney Failure, Chronic
Intervention: Drug: Patiromer 25.2 g
33 Recruiting Renal Osteodystrophy: An Individual Management Approach
Condition: Kidney Failure, Chronic
Interventions: Drug: Alendronate;   Drug: Teriparatide;   Drug: Cinacalcet
34 Recruiting Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia : Impact on Early Complications
Condition: Kidney Failure, Chronic
Interventions: Drug: Axillary block anesthesia with Ropivacaine and Lidocaine;   Drug: Local anesthesia with Ropivacaine and Lidocaine
35 Recruiting Quantifying the Deterioration of Physical Function in Renal Patients
Condition: End Stage Renal Disease
Intervention: Other: Functional Test
36 Recruiting Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial
Condition: End-Stage Renal Disease
Intervention: Drug: Spironolactone
37 Not yet recruiting Cost Utility Analysis of Haemodialysis and Continuous Ambulatory Peritoneal Dialysis in Ministry of Health Dialysis Centres, Malaysia
Condition: End Stage Renal Disease
Intervention:
38 Recruiting The Effect of Increasing Dialysate Magnesium on Calcification Propensity in Subjects on Haemodialysis
Condition: Endstage Renal Disease
Interventions: Other: Dialysate magnesium (1.0 mmol/L);   Other: Dialysate magnesium (0.5 mmol/L)
39 Not yet recruiting Urgent-start Peritoneal Dialysis in ESRD Patients:Safety and Efficacy
Condition: End-Stage Renal Disease
Interventions: Device: urgent-start peritoneal dialysis catheter;   Device: central venous catheter
40 Not yet recruiting Health Effects of oraL Protein Supplements in HD (The HELPS-HD Trial)
Condition: End Stage Renal Disease
Intervention: Dietary Supplement: Nutritional Supplement

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.